Editorial · 31 Jan 2025
EditorialPublished 30 Nov 2024
Neoadjuvant vs Adjuvant Surgery in Cancer Management
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Neoadjuvant and adjuvant therapies are essential components of modern cancer management. These approaches involve the use of chemotherapy, radiotherapy, or targeted therapy either before (neoadjuvant) or after (adjuvant) surgical resection to improve clinical outcomes. While both strategies aim to reduce the risk of recurrence and improve survival, they are employed in different clinical scenarios, depending on tumor type, stage, and patient characteristics. Neoadjuvant therapy aims to shrink tumors before surgery, facilitating less invasive resections and better surgical outcomes, while adjuvant therapy is administered after surgery to eliminate residual disease and prevent relapse. This article compares neoadjuvant and adjuvant approaches, highlighting the evidence supporting their use, key differences, and challenges associated with each. The goal is to provide a clearer understanding of the evolving role of these strategies in optimizing cancer treatment.
Keywords
Subjects
Oncology & CancerSurgeryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Surgery.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Surgery
- SubjectOncology & Cancer
- SubjectSurgery
- BylineArticles whose byline prints “Astrid Vestergaard”
